Drug and Vaccine Pricing and Innovation: What is the Story?

被引:2
|
作者
Pauly, Mark V. [1 ]
机构
[1] Univ Penn, Wharton Sch, Hlth Care Syst Dept, Room 208 Colonial Penn Ctr,3641 Locust Walk, Philadelphia, PA 19104 USA
关键词
D O I
10.1002/mde.1351
中图分类号
F [经济];
学科分类号
02 ;
摘要
[No abstract available]
引用
收藏
页码:407 / 413
页数:7
相关论文
共 50 条
  • [31] What a Story?
    Martin, Andrew W.
    Rafail, Patrick
    McCarthy, John D.
    SOCIAL FORCES, 2017, 96 (02) : 779 - 802
  • [32] What is the story?
    Lumb, Philip D.
    JOURNAL OF CRITICAL CARE, 2016, 31 (01) : 1 - 1
  • [33] Market entry, power, pharmacokinetics: what makes a successful drug innovation?
    Alt, Susanne
    Helmstaedter, Axel
    DRUG DISCOVERY TODAY, 2018, 23 (02) : 208 - +
  • [34] Drivers of innovation value: simulation for new drug pricing evaluation based on system dynamics modelling
    Xing, Qian
    Cheng, Wendi
    Wang, Wei
    Jin, Chunlin
    Wang, Haiyin
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [35] WHAT PRICE PRICING
    PATSTONE, W
    EDN MAGAZINE-ELECTRICAL DESIGN NEWS, 1980, 25 (07): : 29 - 29
  • [36] Finding a new drug and vaccine for emerging swine flu: What is the concept?
    Wiwanitkit, Viroj
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 377 - 383
  • [37] THE IMPACT OF ORPHAN DRUG INCENTIVES ON INNOVATION AND PRICING IN NICHE THERAPEUTIC MARKETS: A SYSTEMATIC REVIEW OF THE LITERATURE
    Kapur, A. K.
    VALUE IN HEALTH, 2012, 15 (07) : A291 - A291
  • [38] Nasal vaccine innovation
    Jabbal-Gill, Inderjit
    JOURNAL OF DRUG TARGETING, 2010, 18 (10) : 771 - 786
  • [39] Drug Pipeline for MASLD: What Can Be Learned from the Successful Story of Resmetirom
    Knezovic, Elizabeta
    Hefer, Marija
    Blazanovic, Suzana
    Petrovic, Ana
    Tomicic, Vice
    Srb, Nika
    Kirner, Damir
    Smolic, Robert
    Smolic, Martina
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2025, 47 (03)
  • [40] Drug pricing debate
    Canan, Stacie S.
    CHEMICAL & ENGINEERING NEWS, 2017, 95 (16) : 3 - 3